| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.2M | +57.1% |
| Cost of Revenue | $3.8M | +35.0% |
| Gross Profit | $21.4M | +61.8% |
| R&D Expense | $2.4M | -55.6% |
| SG&A Expense | $31.2M | +14.8% |
| Operating Income | -$12.2M | +36.9% |
| Pre-tax Income | -$12.0M | +37.0% |
| Income Tax | -$93K | +50.0% |
| Net Income | -$11.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -66.6% |
| Short-term Investments | $8.5M | — |
| Accounts Receivable | $1.4M | +90.7% |
| Inventory | $1.7M | -22.4% |
| Current Assets | $16.3M | +14.0% |
| Total Assets | $20.5M | +27.1% |
| Current Liabilities | $9.2M | +12.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | +52.6% |
| Capital Expenditures | $206K | +0.0% |
| Investing Cash Flow | -$8.5M | -4035.4% |
| Financing Cash Flow | $8.4M | +12.7% |
| Free Cash Flow | -$7.2M | +51.9% |
| +36.9% |
| EPS (Basic) | -$1.59 | +53.5% |
| EPS (Diluted) | -$1.59 | +53.5% |
| Total Liabilities |
| $12.9M |
| +49.3% |
| Stockholders' Equity | $7.5M | +1.4% |